Cardiac remodeling in the mouse model of marfan syndrome develops into two distinctive phenotypes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 310, Issue 2, 2016, Pages H290-H299

  Tae, Hyun Jin ^a   Petrashevskaya, Natalia ^a   Marshall, Shannon ^a   Krawczyk, Melissa ^a   Talan, Mark ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Cardiac function; Fibrillin 1; Marfan syndrome; Myocardial hypertrophy

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD2 PROTEIN; SMAD3 PROTEIN; ACTIN BINDING PROTEIN; FBN1 PROTEIN, MOUSE; FIBRILLIN; FIBRILLIN 1; SMAD2 PROTEIN, MOUSE; SMAD3 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART ATRIUM REMODELING; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE; HEMODYNAMICS; INFERIOR CAVA VEIN OBSTRUCTION; MALE; MARFAN SYNDROME; MITRAL VALVE REGURGITATION; MOUSE; NONHUMAN; PHENOTYPE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CARDIAC MUSCLE; CARDIOMEGALY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FIBROSIS; GENETICS; HEART LEFT VENTRICLE FUNCTION; METABOLISM; MITRAL VALVE INSUFFICIENCY; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMEGALY; FIBRILLIN-1; FIBRILLINS; FIBROSIS; HEMODYNAMICS; MALE; MAP KINASE SIGNALING SYSTEM; MARFAN SYNDROME; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; MITRAL VALVE INSUFFICIENCY; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; ULTRASONOGRAPHY; VENTRICULAR FUNCTION, LEFT;

EID: 84954542622     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00354.2015     Document Type: Article

References (41)

1. Ahluwalia N, Blacher J, de Edelenyi FS, Faure P, Chantal J, Hercberg S, Galan P. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease. Atherosclerosis 228: 478-484, 2013
2. Boileau C, Guo DC, Hanna N, Regalado ES, Detaint D, Gong L, Varret M, Prakash SK, Li AH, d’Indy H, Braverman AC, Grandchamp B, Kwartler CS, Gouya L, Santos-Cortez RL, Abifadel M, Leal SM, Muti C, Shendure J, Gross MS, Rieder MJ, Vahanian A, Nickerson DA, Michel JB; National Heart, Lung, and Blood Institute (NHLBI) Go Exome Sequencing Project, Jondeau G, Milewicz DM. TGFβ2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet 44: 916-921, 2012
3. Bouzeghrane F, Reinhardt DP, Reudelhuber TL, Thibault G. Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis. Am J Physiol Heart Circ Physiol 289: H982-H991, 2005
4. Canadas V, Vilacosta I, Bruna I, Fuster V. Marfan syndrome Pathophysiology and diagnosis. Nat Rev Cardiol 7: 256-265, 2010
5. Cañadas V, Vilacosta I, Bruna I, Fuster V. Marfan syndrome Treatment and management of patients. Nat Rev Cardiol 7: 266-276, 2010
6. Cook JR, Carta L, Bénard L, Chemaly ER, Chiu E, Rao SK, Hampton TG, Yurchenco P; GenTAC Registry Consortium, Costa KD, Hajjar RJ, Ramirez F. Abnormal muscle mechanosensing triggers cardiomyopathy in mice with Marfan syndrome. J Clin Invest 124: 1329-1339, 2014
7. De Backer JF, Devos D, Segers P, Matthys D, François K, Gillebert TC, De Paepe AM, De Sutter J. Primary impairment of left ventricular function in Marfan syndrome. Int J Cardiol 112: 353-358, 2006
8. Dietz HC, Mecham RP. Mouse models of genetic diseases resulting from mutations in elastic fiber proteins. Matrix Biol 19: 481-488, 2000
9. Gao LG, Luo F, Hui RT, Zhou XL. Recent molecular biological progress in Marfan syndrome and Marfan-associated disorders. Ageing Res Rev 9: 363-368, 2010
10. 2+ channel activity induces hypertrophy and heart failure in mice. J Clin Invest 122: 280-290, 2012
11. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Losartan, an AT1 antagonist, prevents aortic aneurism in a mouse model of Marfan syndrome. Science 312: 117-121, 2006
12. Hinton RB Jr, Alfieri CM, Witt SA, Glascock BJ, Khoury PR, Benson DW, Yutzey KE. Mouse heart valve structure and function: echocardiographic and morphometric analyses from the fetus through the aged adult. Am J Physiol Heart Circ Physiol 294: H2480-H2488, 2008
13. Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, Loeys BL, Thomas CJ, Patnaik S, Marugan JJ, Judge DP, Dietz HC. Noncanonical TGF-_ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332: 358-361, 2011
14. 2+ control calcineurin-NFAT signaling and pathologic hypertrophy in cardiac myocytes? Sci Signal 24: 31, 2008
15. Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB, Sakai LY. Latent transforming growth factor-beta binding protein 1 interacts with fibrillin and is microfibrilassociated protein. J Biol Chem 278: 2750-2757, 2003
16. Jeremy RW, Huang H, Hwa J, McCarron H, Hughes CF, Richards JG. Relation between age, arterial distensibility and aortic dilatation in the Marfan syndrome. Am J Cardiol 74: 369-374, 1994
17. Jondeau G, Boutouyrie P, Lacolley P, Laloux B, Dubourg O, Bourdarias JP, Laurent S. Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. Circulation 99: 2677-2681, 1999
18. Judge DP, Biery NJ, Keene DR, Geubtner J, Myers L, Huso DL, Sakai LY, Dietz HC. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J Clin Invest 114: 172-181, 2004
19. Judge DP, Dietz HC. Marfan syndrome. Lancet 366: 1965-1976, 2005
20. Kiotsekoglou A, Bajpai A, Bijnens BH, Kapetanakis V, Athanassopoulos G, Moggridge JC, Mullen MJ, Nassiri DK, Camm J, Sutherland GR, Child AH. Early impairment of left ventricular long-axis systolic function demonstrated by reduced atrioventricular plane displacement in patients with Marfan syndrome. Eur J Echocardiogr 9: 605-613, 2008
21. Kiotsekoglou A, Saha SK, Moggridge JC, Kapetanakis V, Bijnens BH, Mullen MJ, Camm J, Sutherland GR, Wilkinson IB, Child AH. Effect of aortic stiffness on left-ventricular long-axis systolic function in adults with Marfan syndrome. Hellenic J Cardiol 51: 501-511, 2010
22. Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E, Kass DA. Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload. J Clin Invest 121: 2301-2312, 2011
23. Lindsay ME, Shepers D, Ajit Bolar NA, Doyle JJ, Gallo E, Fert-Bober J, Kempers MJ, Fishman EK, Chen Y, Myers L, Bjeda D, Oswald G, Elias AF, Levy HP, Anderlid BM, Yang MH, Bongers EM, Timmermans J, Braverman AC, Canham N, Mortier GR, Brunner HG, Byers PH, Van Yek J, Van Laer LJ, Dietz HC, Loyes BL. Loss-of-function mutations in TGF-β2 cause a syndromic presentation of thoracic aortic aneurism. Nat Genet 44: 922-927, 2012
24. Mariko B, Ghandour Z, Raveau S. Microfibrills and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells. Am J Physiol Cell Physiol 299: C977-C987, 2010
25. Matsumoto-Ida M, Takimoto Y, Aoyama T, Akao M, Takeda T, Kita T. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 290: H709-H715, 2006
26. Mizuguchi T, Matsumoto N. Recent progress in genetics of Marfan syndrome and Marfan associated disorders. J Hum Genet 52: 1-12, 2007
27. Mudd JO, Kass DA. Taking the heart failure in the twenty-first century. Nature 451: 919-928, 2008
28. Nataatmadja M, West J, West M. Overexpression of transforming growth factor beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurism. Circulation 114: 1371-13775, 2006
29. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. Dysregulation of TGFbeta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33: 407-411, 2003
30. Ng CM, Cheng A, Myers LA, Martinez-Murillo F, Jie C, Bedja D, Gabrielson KL, Hausladen JM, Mecham RP, Judge DP, Dietz HC. TGF-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114: 1586-1592, 2004
31. Ramirez F, Dietz HC. Fibrillin-rich microfibrills: structural determinants of morphogenetic and homeostatic events. J Cell Physiol 213: 326-330, 2007
32. Rybczynski M, Koschyk DH, Aydin MA, Robinson PN, Brinken T, Franzen O, Berger J, Hofmann T, Meinertz T, von Kodolitsch Y. Tissue Doppler imaging identifies myocardial dysfunction in adults with Marfan syndrome. Clin Cardiol 30: 19-24, 2007
33. Savolainen A, Nisula L, Keto P, Hekali P, Viitasalo M, Kaitila I, Kupari M. Left ventricular function in children with the Marfan syndrome. Eur Heart J 15: 625-630, 1994
34. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan syndrome. N Engl J Med 330: 1335-1341, 1994
35. Swaney JS, Roth DM, Olson ER, Naugle JE, Meszaros JG, Insel PA. Inhibition of cardiac myofibroblast formation and collage synthesis by activation and overexpression of adenylyl cyclase. Proc Natl Acad Sci U S A 102: 437-442, 2005
36. Syed F, Diwan A, Hahn HS. Murine echocardiography: a practical approach for phenotyping genetically manipulated and surgically modeled mice. J Am Soc Echocardiogr 18: 982-990, 2005
37. Vitarelli A, Conde Y, Cimino E, D’Angeli I, D’Orazio S, Stellato S, Padella V, Caranci F. Aortic wall mechanics in the Marfan syndrome assessed by transesophageal tissue Doppler echocardiography. Am J Cardiol 97: 571-577, 2006
38. Wilson DG, Bellamy MF, Ramsey MW, Goodfellow J, Brownlee M, Davies S, Wilson JF, Lewis MJ, Stuart AG. Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation. Circulation 99: 909-915, 1999
39. Yang B, Larson DF, Watson R. Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationship. Am J Physiol Heart Circ Physiol 277: H1906-H1913, 1999
40. Yetman AT, Bornemeier RA, McCrindle BW. Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol 41: 329-332, 2003
41. Zhu W, Petrashevskaya N, Ren S, Zhao A, Chakir K, Gao E, Chuprun JK, Wang Y, Talan M, Dorn GW 2nd, Lakatta EG, Koch WJ, Feldman AM, Xiao RP. Gi-biased β2-AR signaling links GRK2 up-regulation to heart failure. Circ Res 110: 265-274, 2012